More Cambium Bio Ltd news Cambium Bio LtdASX: CMB FDA Approves Elate Ocular Phase 3 Clinical Trial Protocol Feb 25, 2025 at 4:36 AM UTC As issuedPlain English Cambium Bio Limited has released a press release. View Attachment
